Schedule 13G ownership disclosure

HOMOLOGY MEDICINES INC

Common Stock, $0.0001 par value per share · CUSIP: 438083107

Event date: 2024-03-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ADAR1 Partners, LP

    Shares: 3,120,824.00 · Class: 5.4%

  • ADAR1 Capital Management, LLC

    Shares: 3,120,824.00 · Class: 5.4%

  • ADAR1 Capital Management GP, LLC

    Shares: 3,120,824.00 · Class: 5.4%

  • Daniel Schneeberger

    Shares: 3,120,824.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001758866-24-000004
Form type
SCHEDULE 13G
Filer
ADAR1 Partners, LP
CIK
CIK 1758866
Filed
Mar 14, 2024
Reporting period
Mar 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub